electroCore, Inc. - Common Stock (ECOR)

electroCore (ECOR) Q2 2025 earnings show revenue beat at $7.38M (+20% YoY) but EPS missed at -$0.35, sparking a 20% stock drop. Growth continues, but profitability concerns persist.

Looking for insights into the US markets one hour before the close of the markets on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top gainers and losers in today's session.

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

In this video, I review the market warnings I've shared over the past three weeks and how Friday's session confirmed negative divergences across key metrics signaling weakness.

In this video lesson, I review the resilient overall market, stocks on my radar for the short and long-term portfolio, and a new EOD swing trade, for Tuesday's session. Happy trading. Aloha.

Volatile market? Learn how RCAT, ROOT, and GEO stand out with robust catalysts, sentiment, and fundamentals.

ECOR stock results show that electroCore beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

ECOR stock results show that electroCore beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.